Skadden, Arps, Slate, Meagher & Flom LLP & Affiliates, Capital Markets

About

Provided by Skadden, Arps, Slate, Meagher & Flom LLP & Affiliates

Skadden’s German capital markets practice features German- and U.S.-qualified lawyers with several decades of experience handling complex cross-border equity, equity-linked and debt capital markets transactions in Germany, Austria and Switzerland, particularly involving a strong U.S. component (either U.S. listings or private placements). We advise issuers on corporate, financing, governance and structuring matters to establish capital markets readiness (particularly in the pre-IPO phase). Our attorneys also counsel issuers and underwriters on a broad range of capital markets transactions — including IPOs, secondary share placements, capital increases, equity-linked transactions, high-yield financings (under U.S. and German law) and other global equity and debt offerings — and provide ongoing German and U.S. securities law advice. In addition, Skadden’s capital markets team handles dual listings, SPAC and de-SPAC transactions, depositary receipt programs, redomiciliations and delistings and works closely with the firm’s M&A and Private Equity Groups to deliver seamlessly integrated client service.

Chambers Review

Provided by Chambers

Capital Markets: Equity - Germany

Band 4

What the Team is Known For

Skadden, Arps, Slate, Meagher & Flom is known for its longstanding coverage of ECM matters, frequently advising investment banks and issuers on IPOs on domestic and international stock exchanges. The department is particularly acclaimed for its expertise in the US market but equally active on pan-European multi-jurisdictional deals. The team also offers strength in capital increases, private placements and rights offerings as well as convertibles transactions and de-SPACs.

Wofür das Team bekannt ist

Skadden, Arps, Slate, Meagher & Flom ist bekannt für ihre langjährige Berichterstattung im Bereich ECM-Angelegenheiten und berät häufig Investmentbanken und Emittenten bei Börsengängen an nationalen und internationalen Börsen. Die Abteilung ist besonders für ihre Expertise auf dem US-Markt bekannt, aber auch bei paneuropäischen Transaktionen mit mehreren Jurisdiktionen aktiv. Das Team bietet auch Stärken bei Kapitalerhöhungen, Privatplatzierungen und Bezugsrechtsangeboten sowie bei Wandelanleihetransaktionen und De-SPACs.

View ranking table

Work Highlights

Provided by Skadden, Arps, Slate, Meagher & Flom LLP & Affiliates

Skadden assisted MorphoSys with its EUR2.7 billion public takeover by Novartis and sale of all rights to Incyte Corporation.
Skadden hat MorphoSys bei der öffentlichen Übernahme durch Novartis in Höhe von 2,7 Mrd. EUR und dem Verkauf aller Rechte an die Incyte Corporation unterstützt.

Strengths

Provided by Chambers

Skadden has a strong US focus and capability. The team is highly sophisticated and capable, and I know that nothing will fall through the cracks.